easy-to-interpret, and cost-effective method of copy number analysis of specific DNA sequences, MLPA presents wide clinical utility and may be included in diagnostic workup of ID, particularly when microarrays are unavailable as a firstline approach. Copyright © 2011 S. Karger AG, Basel Intellectual disability (ID) is defined as an intelligence quotient of 70 or lower together with performance lower than age-and culture-related standards in at least 2 areas of adaptive function, starting before 18 years of age [American Psychiatric Association, 2000]. ID is classified as mild, moderate, severe, and profound according to the intelligence quotient score [American Psychiatric Association, 2000]. ID prevalence is 2-3% with 0.3% of the population being severely retarded [Fishburn et al., 1983; Raymond, 2006; Shapiro and Batshaw, 2007] .
Searching for Copy Number Changes in Nonsyndromic X-Linked Intellectual Disability
Clinical workup of patients with ID should include karyotyping and, if clinically indicated, analysis for specific chromosome (Wolf-Hirschhorn, Angelman, Williams, etc.) or single gene (Noonan syndrome, Kabuki syndrome, etc.) disorders. Analysis for subtelomeric rearrangements and fragile X syndrome (FXS) should be routinely performed as these have a high etiological probability among patients with ID [Flint and Knight, 2003; Rooms et al., 2004; Raymond, 2006] .
Single gene causes of ID constitute a large and heterogeneous group, as detected by means of a current OMIM search, which yields nearly 1,700 entries with ID. Many of the known genes lie on the X chromosome [Chelly et al., 2006] . X-linked ID (XLID) is responsible for 10-12% of ID in males [Mandel and Chelly, 2004; Ropers and Hamel, 2005] . FXS caused by full mutations of FMR1 gene is alone responsible for 20-30% of XLID [Fishburn et al., 1983; Chiurazzi et al., 2008] . Although none of the remaining 90 X-linked genes known today are responsible for such a large proportion of ID [Raymond, 2006; Tarpey et al., 2009] , current practice for ID in males involves analysis of known XLID genes. Patients highly suggestive of having XLID include those with pedigrees involving intellectually disabled males from at least 2 different generations related to each other through carrier females (42% yield); those with similarly affected brothers (17% yield), and those with idiopathic ID in whom previous analyses for karyotype, subtelomeric rearrangements and FXS have revealed normal results (10% yield) [de Brouwer et al., 2007; Rogers et al., 2008] .
XLID has been traditionally classified as syndromic or nonsyndromic; however, as with FXS, clinical conditions initially classified as nonsyndromic XLID may be subject to reclassification as syndromic XLID, following revision of clinical experience and molecular data [Madrigal et al., 2007a; Nawara et al., 2008; Vandewalle et al., 2009; Fusco et al., 2010] . Examples include ATRX, OPHN1, MECP2, ARX, PQBP1 , and KDM5C . Although nonsyndromic XLID was initially thought to be a result of point mutations, copy number changes of relevant genes have recently been described as causative. Examples include OPHN1, GDI1 and MECP2 [Madrigal et al., 2007a; Nawara et al., 2008; Vandewalle et al., 2009; Fusco et al., 2010] . Screening for copy number changes in XLID genes may be an important step in etiological testing, as suggested by previous studies [Madrigal et al., 2008] . In this study, the authors aimed to look for such changes in a group of nonsyndromic male patients with presumptive ID.
Patients and Methods
A total of 100 male patients considered likely to have nonsyndromic XLID were included in the study. Gross chromosomal disorders, subtelomeric rearrangements (using FISH) and FXS were previously excluded in all, using methods previously described [Fu et al., 1991; Oberle et al., 1991; Rousseau et al., 1991; Utine et al., 2009] . Where possible, patients with pedigrees suggestive of XLID (affected males from more than one generation related through females or affected brothers) were included. The study was approved by the Ethics Committee of Hacettepe University Faculty of Medicine.
MLPA was performed according to manufacturer's instructions (Salsa P106 and P015, MRC, Holland) . Data analysis was undertaken using Coffalyser MLPA software (www.mlpa.com). This software allows the drawing of visual fragment analysis diagrams, known as electropherograms, following normalization of data using reference DNA. Copy number alterations were calculated as ratios between normalized peak areas and the corresponding mean of normalized peak areas from a male reference data set. Genomic copy number analysis is normal in samples with normalized peak areas of 0.7-1.3 times that of reference DNA samples, whereas outlying results show either a loss of normal genomic copy number (deletion) or a gain in copy number (duplication).
P106 MRX kit (2005 version SNP microarray analysis was performed in order to validate the findings. The Affymetrix Genome-Wide Human SNP Array 6.0 arrays (Affymetrix, Santa Clara, Calif., USA) were performed according to manufacturer's instructions. The average probe spacing of the 6.0 array is 0.7 kb. SNP copy number was assessed using Affymetrix Genotyping Console 3.0 software.
X chromosome inactivation (XCI) pattern was studied by genotyping the highly polymorphic CAG repeat in the AR gene, as previously described [Allen et al., 1992; Özbalkan et al., 2005] . DNA samples from a male control, a female control with random XCI pattern and a female control with an extremely skewed XCI pattern were used.
Results
Two patients out of 100 (2%) had copy number variations of XLID genes: one brother had a duplication of exon 5 of TM4SF2/TSPAN7 gene and another patient (see family 2) had duplication of the entire MECP2 gene.
Family 1
A moderately retarded 9-year-old patient and his similarly affected 11-year-old brother had infantile hypotonia and delayed motor development ( fig. 1 ). They did not acquire language abilities, but were able to communicate well with gestures; both were silent and pleasant in character. There was no history of seizures, stereotypical or aggressive behavior. No dysmorphic characteristics or malformations were present. No other family member was affected. Probe for the exon 5 of TM4SF2/TSPAN7 gene was duplicated in the patient and his similarly affected brother ( fig. 2 ) . SNP microarray analysis revealed duplication of a 143 kb long segment at Xp11.4 at 38.37-38.5 Mb. Consistent with the MLPA results, the duplication excluded exon 1, but included all the remaining 6 exons ( fig. 3, 4 ) . The mother, who was healthy, had 3 copies of the same region ( fig. 3, 4 ) . XCI analysis of the mother was done for this family and was found noninformative ( fig. 5 ) .
Family 2
An 8-year-old boy had severe intellectual disability and infantile hypotonia leading to a delay in motor function development. He experienced recurrent respiratory infections and displayed autistic behavior with stereotypical hand movements, accompanied by very limited speech. He also displayed brachycephaly, hypotonic facies, very short and infrequent eye contact, and drooling ( fig. 6 ). He did not experience seizures, but an epileptic pattern was detected in the EEG. The daughter of a maternal aunt suffered from ID, and the son of another maternal aunt showed speech delay without ID. MLPA identified duplications of all probes for MECP2 gene as well as probes for the flanking IRAK1 and L1CAM genes ( fig. 7 ) . SNP microarray analysis confirmed the duplication of a 509 kb long segment localized at Xq28 between 152.8-153.3 Mb ( fig. 8 ). The mother, who was healthy, had the same duplication, leading to 3 copies of the region ( fig. 8 ) . 
Discussion
Over the last 10 years, copy number changes in XLID genes as causes of syndromic and nonsyndromic ID, including MECP2, GDI1, IL1RAPL1 , and OPHN1 , have been discussed [Madrigal et al., 2007a; Nawara et al., 2008; Vandewalle et al., 2009; Fusco et al., 2010] . Syndromic nature of these genomic diseases have already been established for some genes (MECP2, GDI1, OPHN1) [Meins et al., 2005; van Esch et al., 2005; Friez et al., 2006; Madrigal et al., 2007a; Lugtenberg et al., 2009] . For others, it is still under investigation whether copy number changes, particularly duplications, are causative for ID [Bauters et al., 2008; Madrigal et al., 2008; Gijsbers et al., 2011] .
Whether copy number changes in other X-linked genes cause XLID may become evident with future research. MECP2 duplication in affected males was first reported in 2005 [Meins et al., 2005; van Esch et al., 2005] , GDI1 duplication in 2007 [Madrigal et al., 2007a] and IL-1RAPL1 deletion in 2008 [Nawara et al., 2008] . Severe intellectual disability, infantile hypotonia, delay in motor function development, recurrent respiratory infections, autistic behavior, stereotypical hand movements, limited speech with hypotonic facies, short and infrequent eye contact, and drooling in patient 2 are consistent and wellknown features of MECP2 duplication. However, copy number changes in TM4SF2/TSPAN7 are yet unclear as causes of ID.
ID, autism and schizophrenia are 3 pathological conditions which probably share common biological pathways for neurotransmission, synapse formation and maintenance, involving common gene products [Gulimatre at al., 2009; Piton et al., 2010] . Some recent studies showed evidence against the causative role of TM4SF2/ TSPAN7 duplications in autism spectrum disorders and schizophrenia [Cai et al., 2008; Noor et al., 2009; Piton et al., 2010] . In ID, a causative deletion in TM4SF2/TSPAN7 gene was previously described in 1 male patient [Madrigal et al., 2007b] and duplications in TM4SF2/TSPAN7 were reported in 2 families [Froyen et al., 2007] . In the latter report, the affected individuals included 2 brothers in one family and a single male patient in a second family. The 2 brothers, who had moderate-severe ID, autism, epilepsy, hypogenitalism, and cerebellar hypoplasia, had a complex cytogenetic rearrangement with a coexistent deletion in OPHN1 gene, which was apparently causative for the clinical findings. In the second family, a cytogenetically visible large deletion of 15.5 Mb at Xp11.4p21.3 spanning 41 genes, including IL1RAPL1 , was present and was likely to be causative for ID . His mother, who had borderline ID, also had the same duplication of TM4SF2/ TSPAN7 . It was difficult to conclude that in these 2 families the TM4SF2/TSPAN7 duplication was causative. Similarly, large duplications of Xp11p21 involving many XLID genes were shown in 2 patients in 2008; the roles of individual genes in ID, not unexpectedly, being unclear [Tzschach et al., 2008] . The isolated duplication of TM4SF2/TSPAN7 in both brothers reported in this study demonstrated by SNP array analysis might suggest the presence of a clinical phenotype with ID in cases where such duplications occur, although this observation is certainly inadequate for making a definitive conclusion. Unfortunately, XCI study of maternal DNA revealed noninformative results because of homozygosity in CAG repeat number in the AR gene. Features of both brothers in our study and the patients from Froyen et al. [2007] are presented in table 1 . MLPA procedure identifies copy number changes for multiplex short DNA sequences efficiently, rapidly and reliably. The procedure is easy to perform and easy to interpret and has a wide variety of uses in clinical laboratories. Although nonsyndromic ID may be highly heterogeneous in etiology and the diagnostic yield of MLPA in MRX may be very low, as seen in the current study, for families in which affected males from different generations who are related to each other through females, the technique may provide diagnostic results as high as 5-10% [Madrigal et al., 2007a [Madrigal et al., , b, 2008 .
The current consensus across many laboratories is to perform microarrays initially in patients displaying ID with or without malformations/dysmorphisms. Array CGH is desirable as a first-line approach, but in cases where it is not easily available, MLPA screening may be considered a cost-effective prescreening, as there are recently shown examples of causative copy number changes in XLID genes. 
